Medicare Enrolled
Dr. Steven Mattleman, M.D.
Cardiovascular Disease · Jenkintown, PA
Practice pattern: Electrophysiology & Cardiac
— Practice combining electrophysiology and cardiac services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mattleman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mattleman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mattleman
Dr. Steven Mattleman is a cardiovascular disease specialist in Jenkintown, PA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Mattleman performed 4,895 Medicare services across 2,634 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mattleman received a total of $4,084 from 32 pharmaceutical and/or device companies across 227 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mattleman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 8% volume in PA
$4,084 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,895
Medicare services
Top 8% in PA for cardiovascular disease
2,634
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~233 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,638 | $11 | $70 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,101 | $98 | $275 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
389 | $42 | $140 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
361 | $159 | $685 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
357 | $142 | $350 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
223 | $68 | $190 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
213 | $8 | $30 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
147 | $52 | $450 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
139 | $54 | $386 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
135 | $370 | $1,150 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
49 | $130 | $350 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
38 | $65 | $130 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
22 | $166 | $765 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
21 | $7 | $60 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
19 | $78 | $275 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
16 | $19 | $90 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
15 | $2 | $89 |
| Follow-up ultrasound of heart blood flow, valves and chambers An ultrasound exam that follows up on the heart's blood flow, valves, and chambers. It uses sound waves to create images of the heart's structure and function. |
12 | $6 | $25 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.6% high complexity
17.6% medium
74.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,084
Total received (2018-2024)
Avg $583/year across 7 years
Top 37% in PA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
227
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,084 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$924
2023
$581
2022
$476
2021
$145
2020
$309
2019
$961
2018
$689
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$189
Janssen Pharmaceuticals, Inc
$143
PFIZER INC.
$140
Merck Sharp & Dohme LLC
$84
Kestra Medical Technology Services, Inc.
$68
Amgen Inc.
$56
Philips North America LLC
$48
E.R. Squibb & Sons, L.L.C.
$34
AstraZeneca Pharmaceuticals LP
$28
Alnylam Pharmaceuticals Inc.
$26
Lexicon Pharmaceuticals, Inc.
$25
Novo Nordisk Inc
$18
Kiniksa Pharmaceuticals International, plc
$18
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
SANOFI-AVENTIS U.S. LLC
$15
Top 3 companies account for 51.0% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$799
Janssen Pharmaceuticals, Inc
$429
Novartis Pharmaceuticals Corporation
$386
Amgen Inc.
$330
Boston Scientific Corporation
$286
E.R. Squibb & Sons, L.L.C.
$272
SANOFI-AVENTIS U.S. LLC
$225
AstraZeneca Pharmaceuticals LP
$146
BOSTON SCIENTIFIC CORPORATION
$124
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$122
Merck Sharp & Dohme LLC
$120
Astellas Pharma US Inc
$76
Amarin Pharma Inc.
$72
Regeneron Healthcare Solutions, Inc.
$69
Kestra Medical Technology Services, Inc.
$68
Abbott Laboratories
$66
Boehringer Ingelheim Pharmaceuticals, Inc.
$63
Philips Electronics North America Corporation
$61
Philips North America LLC
$48
Lexicon Pharmaceuticals, Inc.
$43
Daiichi Sankyo Inc.
$43
Alnylam Pharmaceuticals Inc.
$40
Allergan Inc.
$31
GE HealthCare
$24
Baxter Healthcare
$24
Braemar Manufacturing, LLC
$19
Novo Nordisk Inc
$18
Kiniksa Pharmaceuticals International, plc
$18
Althera Pharmaceuticals LLC
$18
Kiniksa Pharmaceuticals, Ltd.
$17
Edwards Lifesciences Corporation
$17
Kowa Pharmaceuticals America, Inc.
$12
Top 3 companies account for 39.5% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (7999) SRC Undivided · (CK4) MCOT · AMVUTTRA · Arcalyst · Assure WCD · BRILINTA · BYSTOLIC · CAMZYOS · CHANTIX · Cardiac Monitoring Suite · Circulatory Support · Corlanor · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · FARXIGA · Hillrom - Carnation Ambulatory Monitor · INJECTAFER · Inpefa · JARDIANCE · LEQVIO · LEXISCAN · Lexiscan · LifeVest · Livalo · MULTAQ · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Repatha · Roszet · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · VERQUVO · VYNDAQEL · Vascepa · WAINUA · WATCHMAN · WATCHMAN Access System · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
748
Per 100K population
86.9
County median income
$111,521
Nearest hospital
HOLY REDEEMER HOSPITAL AND MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mattleman is an electrophysiology & cardiac specialist, with above-average Medicare volume (top 8% in PA), with low-engagement industry engagement, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mattleman experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Mattleman performed 1,638 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mattleman receive payments from pharmaceutical companies?
Yes. Dr. Mattleman received a total of $4,084 from 32 companies across 227 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mattleman's costs compare to other cardiologists in Jenkintown?
Dr. Mattleman's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mattleman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Jenkintown
Browse cardiologists in Jenkintown ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in PA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in PA
Which PA cardiologists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology